Bafna Pharmaceuticals Limited filed its Q4FY26 certificate under SEBI Depositories Regulation 74(5) for the quarter ended March 31, 2026. The compliance document, certified by registrar Cameo Corporate Services Limited on April 6, 2026, confirms proper handling of dematerialisation processes and adherence to regulatory timeframes. Company Secretary Mohanachandran A submitted the certificate to BSE and NSE on April 13, 2026, fulfilling quarterly regulatory obligations.
Bafna Pharmaceuticals Submits Q4FY26 SEBI Depositories Compliance Certificate
